316 related articles for article (PubMed ID: 21062445)
1. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection.
Hagau N; Slavcovici A; Gonganau DN; Oltean S; Dirzu DS; Brezoszki ES; Maxim M; Ciuce C; Mlesnite M; Gavrus RL; Laslo C; Hagau R; Petrescu M; Studnicska DM
Crit Care; 2010; 14(6):R203. PubMed ID: 21062445
[TBL] [Abstract][Full Text] [Related]
2. Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6.
Yu X; Zhang X; Zhao B; Wang J; Zhu Z; Teng Z; Shao J; Shen J; Gao Y; Yuan Z; Wu F
PLoS One; 2011; 6(12):e28680. PubMed ID: 22174866
[TBL] [Abstract][Full Text] [Related]
3. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09.
Martinez-Ocaña J; Olivo-Diaz A; Salazar-Dominguez T; Reyes-Gordillo J; Tapia-Aquino C; Martínez-Hernández F; Manjarrez ME; Antonio-Martinez M; Contreras-Molina A; Figueroa-Moreno R; Valdez-Vazquez R; Kawa-Karasik S; Rodríguez-Zulueta P; Flisser A; Maravilla P; Romero-Valdovinos M
J Clin Virol; 2013 Sep; 58(1):108-13. PubMed ID: 23809475
[TBL] [Abstract][Full Text] [Related]
4. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.
Bermejo-Martin JF; Ortiz de Lejarazu R; Pumarola T; Rello J; Almansa R; Ramírez P; Martin-Loeches I; Varillas D; Gallegos MC; Serón C; Micheloud D; Gomez JM; Tenorio-Abreu A; Ramos MJ; Molina ML; Huidobro S; Sanchez E; Gordón M; Fernández V; Del Castillo A; Marcos MA; Villanueva B; López CJ; Rodríguez-Domínguez M; Galan JC; Cantón R; Lietor A; Rojo S; Eiros JM; Hinojosa C; Gonzalez I; Torner N; Banner D; Leon A; Cuesta P; Rowe T; Kelvin DJ
Crit Care; 2009; 13(6):R201. PubMed ID: 20003352
[TBL] [Abstract][Full Text] [Related]
5. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.
To KK; Hung IF; Li IW; Lee KL; Koo CK; Yan WW; Liu R; Ho KY; Chu KH; Watt CL; Luk WK; Lai KY; Chow FL; Mok T; Buckley T; Chan JF; Wong SS; Zheng B; Chen H; Lau CC; Tse H; Cheng VC; Chan KH; Yuen KY
Clin Infect Dis; 2010 Mar; 50(6):850-9. PubMed ID: 20136415
[TBL] [Abstract][Full Text] [Related]
6. Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09.
Bradley-Stewart A; Jolly L; Adamson W; Gunson R; Frew-Gillespie C; Templeton K; Aitken C; Carman W; Cameron S; McSharry C
J Clin Virol; 2013 Sep; 58(1):100-7. PubMed ID: 23790455
[TBL] [Abstract][Full Text] [Related]
7. Clinical aspects and cytokine response in adults with seasonal influenza infection.
Bian JR; Nie W; Zang YS; Fang Z; Xiu QY; Xu XX
Int J Clin Exp Med; 2014; 7(12):5593-602. PubMed ID: 25664078
[TBL] [Abstract][Full Text] [Related]
8. Cytokine response in pediatric patients with pandemic influenza H1N1 2009 virus infection and pneumonia: comparison with pediatric pneumonia without H1N1 2009 infection.
Kim YH; Kim JE; Hyun MC
Pediatr Pulmonol; 2011 Dec; 46(12):1233-9. PubMed ID: 21626718
[TBL] [Abstract][Full Text] [Related]
9. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
Front Immunol; 2021; 12():691879. PubMed ID: 34163488
[TBL] [Abstract][Full Text] [Related]
10. Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults.
Lee N; Wong CK; Chan PK; Chan MC; Wong RY; Lun SW; Ngai KL; Lui GC; Wong BC; Lee SK; Choi KW; Hui DS
PLoS One; 2011; 6(10):e26050. PubMed ID: 22022504
[TBL] [Abstract][Full Text] [Related]
11. Serum activin A and B, and follistatin in critically ill patients with influenza A(H1N1) infection.
Linko R; Hedger MP; Pettilä V; Ruokonen E; Ala-Kokko T; Ludlow H; de Kretser DM
BMC Infect Dis; 2014 May; 14():253. PubMed ID: 24885241
[TBL] [Abstract][Full Text] [Related]
12. Pregnant women infected with pandemic influenza A(H1N1)pdm09 virus showed differential immune response correlated with disease severity.
Periolo N; Avaro M; Czech A; Russo M; Benedetti E; Pontoriero A; Campos A; Peralta LM; Baumeister E
J Clin Virol; 2015 Mar; 64():52-8. PubMed ID: 25728079
[TBL] [Abstract][Full Text] [Related]
13. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.
Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadière B; van der Werf S; Autran B; Carcelain G;
Am J Respir Crit Care Med; 2014 May; 189(10):1240-9. PubMed ID: 24646009
[TBL] [Abstract][Full Text] [Related]
14.
Alagarasu K; Kaushal H; Shinde P; Kakade M; Chaudhary U; Padbidri V; Sangle SA; Salvi S; Bavdekar AR; D'costa P; Choudhary ML
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946862
[TBL] [Abstract][Full Text] [Related]
15. Excess mortality is associated with influenza A (H1N1) in patients with severe acute respiratory illness.
Lobo SM; Watanabe ASA; Salomão MLM; Queiroz F; Gandolfi JV; de Oliveira NE; Covello LHS; Sacillotto GH; de Godoy LG; Simões ES; Frini ICM; Da Silva Teixeira RER; Furlan NP; Dutra KR; Nogueira ML
J Clin Virol; 2019 Jul; 116():62-68. PubMed ID: 31103803
[TBL] [Abstract][Full Text] [Related]
16. Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A(H1N1)v severe pneumonia.
Estella A
J Infect Dev Ctries; 2011 Jul; 5(7):540-3. PubMed ID: 21795823
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
Choreño-Parra JA; Jiménez-Álvarez LA; Cruz-Lagunas A; Rodríguez-Reyna TS; Ramírez-Martínez G; Sandoval-Vega M; Hernández-García DL; Choreño-Parra EM; Balderas-Martínez YI; Martinez-Sánchez ME; Márquez-García E; Sciutto E; Moreno-Rodríguez J; Barreto-Rodríguez JO; Vázquez-Rojas H; Centeno-Sáenz GI; Alvarado-Peña N; Salinas-Lara C; Sánchez-Garibay C; Galeana-Cadena D; Hernández G; Mendoza-Milla C; Domínguez A; Granados J; Mena-Hernández L; Pérez-Buenfil LÁ; Domínguez-Cheritt G; Cabello-Gutiérrez C; Luna-Rivero C; Salas-Hernández J; Santillán-Doherty P; Regalado J; Hernández-Martínez A; Orozco L; Ávila-Moreno F; García-Latorre EA; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
Front Immunol; 2021; 12():593595. PubMed ID: 33995342
[TBL] [Abstract][Full Text] [Related]
18. [Influence of concomitant illness on clinical manifestations and severity of A/H1N1 influenza infection among patients hospitalized in the Hospital of Infectious Diseases in Warsaw--clinical cases].
Cholewińska G; Higersberger J; Podlasin R; Wiercińska-Drapało A; Lipowski D; Olszyńska-Krowicka M; Przyjałkowski W; Horban A
Przegl Epidemiol; 2010; 64(1):21-5. PubMed ID: 20499655
[TBL] [Abstract][Full Text] [Related]
19. Prospective Observational Study on the Association Between Serum Mannose-Binding Lectin Levels and Severe Outcome in Critically Ill Patients with Pandemic Influenza Type A (H1N1) Infection.
Zogheib E; Nyga R; Cornu M; Sendid B; Monconduit J; Jounieaux V; Maizel J; Segard C; Chouaki T; Dupont H
Lung; 2018 Feb; 196(1):65-72. PubMed ID: 29273833
[TBL] [Abstract][Full Text] [Related]
20. Increase in IFNγ(-)IL-2(+) cells in recent human CD4 T cell responses to 2009 pandemic H1N1 influenza.
Weaver JM; Yang H; Roumanes D; Lee FE; Wu H; Treanor JJ; Mosmann TR
PLoS One; 2013; 8(3):e57275. PubMed ID: 23526940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
